News

Cellares and Papillon Therapeutics have announced a strategic collaboration to automate the manufacturing of PPL-001, an investigational gene-edited cell therapy being developed to…
Read More...

GSK has received U.S. Food and Drug Administration (FDA) approval for Jideytro (zidesamtinib), a next-generation targeted therapy for adults with locally advanced or metastatic…
Read More...

Crystalys Therapeutics has secured $130 million in an oversubscribed Series B financing round to support the late-stage clinical development and commercialization of its lead gout…
Read More...

Evogene Ltd. and South Korea-based biotechnology company ELEO Inc. have entered into a strategic scientific collaboration to develop next-generation oral small-molecule therapies…
Read More...

Lonza and Engitix have entered into a licensing agreement aimed at accelerating the development of next-generation antibody-drug conjugates (ADCs), combining Lonza’s established drug…
Read More...

Samsung Biologics has announced an agreement to acquire Swiss contract development and manufacturing organization (CDMO) PolyPeptide Group AG in an all-cash transaction valued at…
Read More...

Halozyme Therapeutics and Incyte have entered into a global collaboration and licensing agreement to develop additional subcutaneous formulations of Incyte's investigational blood…
Read More...

Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment of a second NVIDIA DGX SuperPOD, strengthening its efforts to…
Read More...

Novo Nordisk has filed a lawsuit against Eli Lilly and Company and Lilly USA in the United States, alleging that the pharmaceutical giant's advertising for its blockbuster diabetes and…
Read More...

The European Commission has approved an expanded indication for Crysvita (burosumab), allowing the therapy to be used in infants aged one month to one year with X-linked…
Read More...

Organon and Samsung Bioepis have expanded their long-standing partnership to bring a new biosimilar medicine to patients in Australia, strengthening their efforts to improve access to…
Read More...

Telix Pharmaceuticals has officially opened a new multi-million-dollar radiopharmaceutical research, manufacturing and treatment facility in Melbourne, Australia, marking a major step…
Read More...

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA (enlicitide) 20 mg tablets for adults…
Read More...

Novartis has announced that the US Food and Drug Administration (FDA) has granted traditional approval to Fabhalta (iptacopan) for adults with primary immunoglobulin A nephropathy…
Read More...

Novo Nordisk has announced that the European Commission (EC) has approved Wegovy® pill (oral semaglutide 25 mg) for the treatment of adults living with obesity or overweight with at…
Read More...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending finerenone for adults with heart failure with preserved or mildly reduced…
Read More...

Excalipoint Therapeutics and DP Technology have announced a strategic collaboration to develop a new artificial intelligence (AI) platform designed to speed up the discovery of T-cell…
Read More...

Clinical-stage radiopharmaceutical company AdvanCell has raised US$315 million in an oversubscribed Series D financing round to accelerate the development of its targeted cancer…
Read More...

Merck, known as MSD outside the United States and Canada, has announced positive results from its Phase 3 KEYNOTE-C93 clinical trial evaluating KEYTRUDA (pembrolizumab) as a first-line…
Read More...

Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its supplemental Biologics License Application (sBLA) for Gazyva/Gazyvaro…
Read More...